Aytu BioScience
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $13,888 | $15,135 | $18,452 | $16,221 |
Gross Profit | 9,186 | 10,254 | 12,806 | 10,786 |
EBITDA | 3,284 | -17,419 | 6,035 | 2,634 |
EBIT | 2,481 | -18,713 | 4,718 | 1,461 |
Net Income | 1,965 | -19,818 | 3,994 | 788 |
Net Change In Cash | 13,888 | 15,135 | 18,452 | 16,221 |
Free Cash Flow | -618 | 2,786 | -6,524 | 2,899 |
Cash | 32,630 | 30,952 | 18,173 | 20,398 |
Basic Shares | 19,476 | 6,791 | 8,204 | 8,485 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $66,382 | $65,183 | $107,399 | $96,669 |
Gross Profit | 45,831 | 49,054 | 66,632 | 50,283 |
EBITDA | -4,665 | 1,406 | -3,273 | -27,957 |
EBIT | -10,042 | -5,319 | -12,088 | -38,103 |
Net Income | -13,562 | -15,844 | -17,051 | -108,779 |
Net Change In Cash | 66,382 | 65,183 | 107,399 | 96,669 |
Free Cash Flow | -5,165 | -1,717 | -5,129 | -28,823 |
Cash | 30,952 | 20,006 | 22,985 | 19,360 |
Basic Shares | 6,279 | 5,537 | 3,339 | 1,470 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.09 |
2025-06-30 | -$2.93 |
2025-03-31 | $0.21 |
2024-12-31 | $0.13 |
